Involvement of the opioid system in the anxiolytic effect of diazepam in mice

European Journal of Pharmacology

Volumn 307, Issue 1, 1996, Pages 7-14

  Tsuda, Makoto ^a   Suzuki, Tsutomu ^a   Misawa, Miwa ^a   Nagase, Hiroshi ^b  

^a HOSHI UNIVERSITY   (Japan)

^b TORAY INDUSTRIES INC   (Japan)

Author keywords

Anticonflict effect; Diazepam; Mouse; Vogel type conflict test; Opioid receptor agonist

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; BETA FUNALTREXAMINE; DIAZEPAM; DYNORPHIN A [1-8][1 (N METHYLTYROSINE) 7 (N METHYLARGININE) 8 DEXTRO LEUCINE N ETHYLAMIDE]; DYNORPHIN DERIVATIVE; FLUMAZENIL; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; NALOXONE; NALTRINDOLE; NORBINALTORPHIMINE; OPIATE AGONIST; OPIATE ANTAGONIST; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BEHAVIOR; CONFLICT; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG ANTAGONISM; HYPOTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOTOR COORDINATION; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TRANQUILIZING ACTIVITY;

EID: 0030594642     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00219-1     Document Type: Article

References (51)

1. 2drenoceptor and κ-opioid receptor occupancy promotes closure of neuronal (N-type) calcium channels, Eur. J. Pharmacol. 174, 63.
2. Agmo, A., A. Galvan, A. Heredia and M. Morales, 1995, Naloxone blocks the antianxiety but not the motor effects of benzodiazepines and pentobarbital: experimental studies and literature review, Psychopharmacology 120, 186.
3. Billingsley, M.L. and R.K. Kubena, 1978, The effects of naloxone and picrotoxin on the sedative and anticonflict effects of benzodiazepines. Life Sci. 22, 897.
4. Britton, K.T., J. Morgan, J. Rivier, W. Vale and G.F. Koob, 1985, Chlordiazepoxide attenuates response suppression induced by corticotropin-releasing factor in the conflict test, Psychopharmacology 86, 170.
5. Britton, K.T., G. Lee, W. Vale, J. Rivier and G.F. Koob, 1986, Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' action of CRF in the rat, Brain Res. 369, 303.
6. Britton, K.T., G. Lee and G.F. Koob, 1988, Corticotropin releasing factor and amphetamine exaggerate partial agonist properties of benzodiazepine antagonist Ro 15-1788 in the conflict test, Psychopharmacology 94, 306.
7. Chavkin, C. and A. Goldstein, 1981, Specific receptor for the opioid peptide dynorphin: structure-activity relationships, Proc. Natl. Acad. Sci. USA 78, 6543.
8. Chavkin, C., I.F. James and A. Goldstein, 1982, Dynorphin is a specific endogenous ligand of the κ-opioid receptor, Science 215, 413.
9. Chen, Y., A. Mestek, J. Liu, J.A. Hurley and L. Yu, 1993, Molecular cloning and functional expression of a μ-opioid receptor from rat brain, Mol. Pharmacol. 44, 8.
10. Comer, S.D., E.M. Hoenicke, A.I. Sable, R.W. Mcnutt, K.J. Chang, B.R.D. Costa, H.I. Mosberg and J.H. Woods, 1993, Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice, J. Pharmacol. Exp. Ther. 267, 888.
11. Cui, Y., T.-F. Lee and C.H. Wang, 1994, Species difference in the modulatory effect of κ agonist on 5-HT release from ground squirrel and rat hippocampus, Neurosci. Lett. 175, 126.
12. Duka, T. and D.N. Stephens, 1986, Potentiation of the propunishment, but not convulsant action of the β-carboline DMCM by naltrexone, Pharmacol. Biochem. Behav. 25, 595.
13. Duka, T., R. Cumin, W. Haefely and A. Herz, 1981, Naloxone blocks the effect of diazepam and meprobamate on conflict behaviour in rats, Pharmacol. Biochem. Behav. 15, 115.
14. Duka, T., M.J. Millan, B. Ulsamer and A. Doenicke, 1982, Naloxone attenuates the anxiolytic action of diazepam in man, Life Sci. 31, 1833.
15. Endoh, T., H, Matsuura, C. Tanaka and H. Nagase, 1992, Nor-binaltorphirnine: A potent and selective κ-opioid receptor antagonist with long-lasting activity in vivo, Arch. Int. Pharmacodyn. 316, 30.
16. Evans, C.J., D.E. Keith, Jr., H. Morrison, K. Magendzo and R.H. Edwards, 1992, Cloning of a delta opioid receptor by functional expression, Science 258, 1952.
17. Funada, M., T. Suzuki, M. Narita, M. Misawa and H. Nagase, 1993, Blockade of morphine reward through the activation of κ-opioid receptors in mice, Neuropharmacology 32, 1315.
18. Gacel, G.A., E. Fellion, A. Baamonde, V. Dauge and R.P. Roques, 1990, Synthesis, biochemical and Pharmacological properties of BUBUC, highly selective and systemically active agonist for in vivo studies of δ-opioid receptors, Peptides, 11, 983.
19. Goldstein, A. and A. Naidu, 1989, Multiple opioid receptors: ligand selectivity profiles and binding site signatures, Mol. Pharmacol. 36, 265.
20. Hughes J., P. Borden, B. Costall, A. Domeney, E. Kelly, D.C. Horwell, J.C. Hunter, R.D. Pinnock and G.N. Woodruff, 1990, Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity, Proc. Natl. Acad. Sci. USA 87, 6728.
21. Hunkeler, W., H. Mohler, L. Fieri, P. Pole, E.P. Bonetti, R. Cumin, R. Schaffner and W. Haefely, 1981, Selective antagonists of benzodiazepines, Nature 290, 514.
22. Kataoka, Y., K. Shibata, K. Yamashita and S. Ueki, 1987, Differential mechanisms involved in the anticontlict action of benzodiazepines injected into central amygdala and mammillary body, Brain Res. 416, 243-247.
23. Lord, A.H., J. Watt, S. Karll and H.W. Kosterlitz, 1977, Endogenous opioid peptides: multiple agonists and receptors, Nature 267, 495.
24. Martin, W.R., C.G. Eades, J.A. Thompson, R.E. Huppler and P.E. Gilbert, 1976, The effects of morphine-and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog, J. Pharmacol. Exp. Ther. 197, 517.
25. Mansour, A., H. Khachaturian, M.E. Lewis, H. Akil and S.J. Watoson, 1987, Autoradiographic differentiation of mu, delta and kappa opioid receptors in the rat forebrain and midbrain, J. Neurosci. 7, 2445.
26. Mansour, A., H. Khachaturian, M.E. Lewis, H. Akil and S.J. Watson, 1988, Anatomy of CNS opioid receptors, Trans Neurosci. 11, 308.
27. 1 Receptor mRNA distribution in the rat CNS: comparison to κ receptor binding and prodynorphin mRNA, Mol. Cell. Neurosci. 5, 124.
28. Mulder, A.H., G. Wardeh, F. Hogenboom and L. Frankhuyzen, 1989, Selectivity of various opioid peptides towards delta-, kappa-and mu-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the brain, Neuropeptides 14, 99.
29. Nagy, J., K. Zembo and L. Desci, 1979, Anti-anxiety action of diazepam after intra-amygdaloid application in the rat, Neuropharmacology 18, 573.
30. B receptor antagonist potentiates μ-, but not δ-opioid receptor-mediated antinociception in the formalin test, Eur. J. Pharmacol. 273, 145.
31. Noble, F., M. Soleilhac, E. Soroca-Lucas, S. Turcaud, M.C. Fournie-Zaluski and B.P. Roques, 1992, Inhibition of the enkephalin-metabolizing enzymes by first systematically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats, J. Pharmacol. Exp. Ther. 261, 181.
32. Phillai, N.P. and D.H. Ross, 1986, Interaction of κ opioid agonists with calcium channel antagonists in the modulation of hypothermia, Eur. J. Pharmacol. 132, 237.
33. Privette, T.H. and D.M. Terrian, 1995, Kappa opioid agonists produce anxiolytic-like behavior on the elevated plus-maze, Psychopharmacology 118, 444.
34. Scheel-Krüger, J. and E.N. Petersen, 1982, Anticonflict effect of the benzodiazepines mediated by a GABAergic mechanism in the amygdala, Eur. J. Pharmacol. 82, 115.
35. Shibata, K., Y. Kataoka, Y. Gomita and S. Ueki, 1982, Localization of the site of the anticonflict action of benzodiazepines in the amygdaloid nucleus of rats, Brain Res. 234, 442.
36. Shibata, K., Y. Kataoka, K. Yamashita and S. Ueki, 1986, An important role the central amygdaloid nucleus and mammillary body in the mediation of conflict behavior in rats, Brain Res. 372, 159.
37. Shibata, S., K. Yamashita, E. Yamamoto, T. Ozaki and S. Ueki, 1989, Effects of benzodiazepine and GABA antagonists on anticonflict effects of antianxiety drug injected into the rat amygdala in a water-lick suppression test, Psychopharmacology 98, 38.
38. Singh, L., A.S. Lewis, M.J. Field, J. Hughes and G.N. Woodruff, 1991, Evidence for an involvement of the brain cholecystokinin B receptor in anxiety, Proc. Natl. Acad. Sci. USA 88, 1130.
39. Soubrie, P., A. Jobert and M. H. Theibot, 1980, Differential effects of naloxone against the diazepam-induced release of behavior in rat in three aversive situations. Psychopharmacology 69, 101.
40. Suzuki, T., M. Funada, M. Narita, M. Misawa and H. Nagase, 1993, Morphine-induced place preference in the CXBK mouse: characteristics of μ opioid receptor subtypes, Brain Res. 602, 45.
41. Suzuki, T., M. Tsuji, T. Mori, M. Misawa, T. Endoh and H. Nagase, 1995, Effects of a highly selective nonpeptide d opioid receptor agonist, TAN-67, on morphiine-induced antinociception in mice, Life Sci. 57, 155.
42. Tortella, F.C., L. Robles and J.W. Holaday, 1985, U50,488, a highly selective kappa opioid: anticonvulsant profile in rats, J. Pharmacol. Exp. Ther. 237, 49.
43. 5]enkephalin in the mouse, Jpn. J. Psychopharmacol. 14, 161.
44. Vogel, J.R., B. Beer and D.E. Clody, 1971, A simple reliable conflict procedure for testing anti-anxiety agents, Psychopharmacologia 21, 1.
45. Von Voigtlander, P.F., E.D. Hall, M.C. Ochoa, R.A. Lewis and H.J. Triezenberg, 1987, U-54494A: a unique anticonvulsant related to kappa opioid agonists, J. Pharmacol. Exp. Ther. 243, 542.
46. Wahlestedt, C., E.M. Pich, G.F. Koob, F. Yee and M. Heilig, 1993, Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides, Science 259, 528.
47. Werling, L.L., P.N. McMahon, P.S. Portoghese, A.E. Takemori and B.M. Cox, 1989, Selective opioid antagonist effects on opioid-induced inhibition of release of norepinephrine in guinea pig cortex, Neuropharmacology 28, 103.
48. Wüster, M., R. Schulz and A. Herz, 1979, Highly specific opiate receptors for dynorphin-(1-13) in the mouse vas deferens, Eur. J. Pharmacol. 62, 235.
49. 45Ca into rat cortical synaptosomes by inhibiting N-but not L-type calcium channels, Neuropharmacology 29, 439.
50. Yamashita, Y., Y. Kataoka, Y Shibata, T. Ozaki, A. Miyazaki, M. Kagoshima and S. Ueki, 1989, Neuroanatomical substrates regulating rat conflict behavior evidenced by brain lesioning, Neurosci. Lett. 104, 195.
51. Yasuda, K., K. Raynor, H. Kong, C.D. Breder, J. Takeda, T. Reisine and G.I. Bell, 1993, Cloning and functional comparison of κ and δ opioid receptors from mouse brain, Proc. Natl. Acad. Sci. USA 90, 6736.